Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker ABOS
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 5, 2026 | ABOS Acumen Pharmaceuticals, Inc. | 2.05 Costs Associated with Exit or Disposal Activities | 8-K | 8-K ↗ |
| Nov 5, 2026 | ABOS Acumen Pharmaceuticals, Inc. | 1.02 Termination of a Material Definitive Agreement | 8-K | 8-K ↗ |
| Oct 30, 2026 | ABOS Acumen Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 30, 2026 | ABOS Acumen Pharmaceuticals, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 26, 2026 | ABOS Acumen Pharmaceuticals, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 26, 2026 | ABOS Acumen Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Sep 16, 2026 | ABOS Acumen Pharmaceuticals, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 12, 2026 | ABOS Acumen Pharmaceuticals, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 12, 2026 | ABOS Acumen Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 16, 2026 | ABOS Acumen Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 16, 2026 | ABOS Acumen Pharmaceuticals, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 3, 2026 | ABOS Acumen Pharmaceuticals, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 12, 2026 | ABOS Acumen Pharmaceuticals, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 12, 2026 | ABOS Acumen Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 26, 2026 | ABOS Acumen Pharmaceuticals, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 26, 2026 | ABOS Acumen Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 16, 2026 | ABOS Acumen Pharmaceuticals, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 16, 2026 | ABOS Acumen Pharmaceuticals, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Mar 16, 2026 | ABOS Acumen Pharmaceuticals, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jan 12, 2026 | ABOS Acumen Pharmaceuticals, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 12, 2025 | ABOS Acumen Pharmaceuticals, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 12, 2025 | ABOS Acumen Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 10, 2025 | ABOS Acumen Pharmaceuticals, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 10, 2025 | ABOS Acumen Pharmaceuticals, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Aug 12, 2025 | ABOS Acumen Pharmaceuticals, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 12, 2025 | ABOS Acumen Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 15, 2025 | ABOS Acumen Pharmaceuticals, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jul 15, 2025 | ABOS Acumen Pharmaceuticals, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jun 5, 2025 | ABOS Acumen Pharmaceuticals, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 13, 2025 | ABOS Acumen Pharmaceuticals, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 13, 2025 | ABOS Acumen Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 27, 2025 | ABOS Acumen Pharmaceuticals, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 27, 2025 | ABOS Acumen Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 12, 2024 | ABOS Acumen Pharmaceuticals, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 12, 2024 | ABOS Acumen Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
35 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:21 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances